UNCY today

$3.55+$0.07 (+2.01%)close Nov 6, 2026

Trend

DailyDowntrend (starting)

4 hourStrong Bearish

1 hourSymmetric Triangle

15 minBearish

5 minStrong Bullish

Daily trend turns up above $24.26

Key levels

Resistance$4.18

Resistance$3.80

Support$3.48

Support$2.02

About Unicycive Therapeutics

Unicycive Therapeutics is a clinical-stage biotechnology company developing therapies for kidney disease. Its lead candidate, oxylanthanum carbonate, is an oral phosphate binder being developed for hyperphosphatemia in chronic kidney disease patients on dialysis. A second candidate, UNI-494, is in development for acute kidney injury. The company operates in the United States and licenses its programs from other drug developers.

Based on the company's 10-K filed Mar 30, 2026.

Nasdaq · Healthcare

Unicycive Therapeutics, Inc. (UNCY)

$3.55+0.07 (+2.01%)

WATCHLISTGrade: BRisk: MEDIUM

1D 5D1M1Y 5Y MaxSign up for all timeframes

High3.59

Low3.45

Open3.46

Volume581K

Avg Vol1.07M

VWAP3.53

30d High4.70

30d Low3.36

30d Chg-23.49%

See full chart with real-time data

What Is the Price Target for UNCY?

SEPT Low Target

$15.00

SEPT Mid Target

$17.50

SEPT High Target

$22.00

Analyst Consensus

$17.50

Current: $3.56Upside: +391.6%Confidence: 65%Method: Analyst Consensus

Is UNCY a Buy or Sell Right Now?

Investability Score

WATCHLIST12-18 months

Thesis

•Revenue growing -29.0% YoY with UNKNOWN trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for UNCY.

Start Free Trial →

Is UNCY Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/B, Analyst Consensus

Fair Value

$14.38

Moat Score

NONE

3/9

Piotroski Score

-3.1

Altman Z-Score

What Is Smart Money Doing with UNCY?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

UNCY Growth Story

Revenue YoY

-29.0%

3yr Revenue CAGR

N/A%

EPS Growth YoY

70.44%

FCF Growth YoY

-9.4%

Revenue Trend

UNKNOWN

Dark Pool Trades for UNCY

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for UNCY, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

Time	Price	Size	Value	Side
21:27:31	$3.59	1,000	$$4K	SELL
21:04:16	$3.55	4,587	$$16K	BUY
21:03:30	$3.53	9,988	$$35K	BUY
20:59:32	$3.56	9,988	$$36K	BUY
20:59:23	$3.55	9,988	$$35K	BUY

5 dark pool trades shown · $$126K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Options Flow for UNCY

PREVIEW

SEPT Investing provides real-time options flow tracking for UNCY, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.

Type	Strike	Expiry	DTE	Premium	Size	Trade
CALL	$5	Nov 20	14	$$300	100	BLOCK
CALL	$5	Feb 19	105	$$160	4	SWEEP

2 options trades shown · 100% calls

Unusual activity, GEX levels, max pain, and dealer positioning

See full options flow

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Unicycive Therapeutics, Inc. (UNCY) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings intelligence, and a complete investment thesis with entry and exit recommendations.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

UNCY — frequently asked questions

What is UNCY stock price today?

Unicycive Therapeutics, Inc. (UNCY) is at $3.55, up 2.01% (+$0.07) at the Nov 6, 2026 close.

Why is UNCY stock moving today?

Latest UNCY news — Oct 22, 2026: FDA accepts Unicycive's resubmitted NDA for oxylanthanum carbonate · Oct 21, 2026: FDA Accepts Unicycive's NDA Resubmission for Oxylanthanum Carbonate

What is the UNCY price target?

The average analyst price target for UNCY is $17.50, ranging from $15 to $22, based on 4 analysts. Latest: Benchmark maintains on Aug 20, 2026.

What do analysts rate UNCY?

Analyst ratings for UNCY: 0 Buy, 7 Hold, 0 Sell — consensus Hold.

Did UNCY beat earnings?

UNCY last reported on Aug 12, 2026: EPS -$0.06 vs -$0.47 expected — a beat of 87.3%.

What are UNCY support and resistance levels?

Support: $3.48, $2.02. Resistance: $3.80, $4.18, $4.50.

What are insiders doing with UNCY?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on UNCY?

Oct 22, 2026: FDA accepts Unicycive's resubmitted NDA for oxylanthanum carbonate · Oct 21, 2026: FDA Accepts Unicycive's NDA Resubmission for Oxylanthanum Carbonate · Sep 29, 2026: Unicycive Resubmits FDA Application for Oxylanthanum Carbonate